left-caret
Insights

advice for businesses in dealing with the expanding coronavirus events

COVID-19 Webinar: Public Company Disclosures

April 03, 2020

By PH COVID-19 Task Force

The spread of the coronavirus continues to spread globally, public companies are facing a myriad of questions and uncertainty as they begin to prepare first quarter reports. In our webinar we discussed liability considerations and advice on disclosure considerations as we navigate these uncertain times. By early March, companies were taking different approaches. We saw that companies that have significant operations or supply chains involving China, or that are particularly vulnerable to the impact of COVID-19, were including more tailored disclosures. Additionally, they began including COVID-19-related disclosures in their MD&A that were customized for their business and industry. We discussed these and other disclosure trends and provided practical guidance around the decision making process about what to disclose.

FEATURED SPEAKERS

111121


Partner, Securities Litigation

116914


Partner, Investigations & White Collar Defense

101463


Partner, Securities & Capital Markets

120588


Of Counsel, Securities & Capital Markets